Answers are grounded in this paper and cite their sources.
Background: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a promising therapeutic approach with risk of Acute Graft-versus-Host-Disease (aGvHD). aGvHD can affect the gastrointestinal tract, which results in gastrointestinal-GvHD (GI-GvHD). We assessed fecal calprotectin (FC) to determine if it can be applied as a GI-GvHD diagnostic marker and the response to steroid therapy.
No takes yet. Share an insight, caveat, or question.
Roshandel et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: